Skip to main content
The University of Iowa
University of Iowa
Office of Innovation

University of Iowa Research Park

Site Main Navigation

  • About the Research Park
    • Board of Directors
    • Our Companies
    • Meet Our Team
  • Properties and Available Spaces
    • Why Lease Here
    • Land Leasing
    • Map
  • Business Incubation
    • The BioVentures Center
      • Facilities
      • Amenities
    • Translation Research Institiute (TRI)
    • Apply for Tenancy
  • Tenant's Hub
  • Resources
  • Contact Us
    • FAQs
stringio (3).jpg

Breadcrumb

  1. Home
  2. News

News

KLAS Report Ranks MediRevv Second in Extended Business Office for Fourth Consecutive Year

Thursday, March 1, 2018

KemPharm Announces FDA Approval of Apadaz™ (benzhydrocodone and acetaminophen) for the Short-Term Management of Acute Pain

Thursday, March 1, 2018

General Dynamics to Acquire CSRA for $9.6 Billion

Thursday, February 22, 2018

Voxello Announces their 4th Major Distribution Partnership

Thursday, February 22, 2018

Ingredient Manufacturer Announces Non-GMO Project Verified Caffeine Ingredient

Thursday, February 15, 2018

CompleWare and VIDA Announce Joint Marketing Agreement for Respiratory Trials

Monday, January 22, 2018

SantosHuman, Inc. Continues to Grow Its Higher Education Segment

Monday, January 8, 2018

KemPharm makes progress on ADHD prodrugs

Thursday, November 16, 2017

Voxello Announces Distribution Partnership with TRL Systems, Inc.

Wednesday, November 8, 2017
Pagination
  • First page « First
  • Previous page ‹ Previous
  • …
  • Page 8
  • Page 9
  • Page 10
  • Page 11
  • Page 12
  • Current page 13
  • Page 14
  • Page 15
  • Page 16
  • Next page Next ›
  • Last page Last »
The University of Iowa
University of Iowa

University of Iowa Research Park

Office of Innovation

BioVentures Center

2500 Crosspark Rd Coralville, Iowa 52241-4710

319-335-4063

research-park@uiowa.edu

Office of Innovation

Social Media

  • Twitter
  • Facebook

Admin Login

  • © 2025 The University of Iowa
  • Privacy Notice
  • UI Nondiscrimination Statement
  • Accessibility